Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Project description:Whole genome sequencing of three Xenorhabdus strains

| PRJNA384510 | ENA

Project description:Whole genome sequencing of Xenorhabdus khoisanae SF87

| PRJNA384512 | ENA

XI_HGB1681

Project description:Xenorhabdus innexi HGB1681 whole genome

| PRJEB17839 | ENA